Adults with a history of strength training were significantly less likely to suffer from knee osteoarthritis and knee pain than were those with no strength training.
A randomized controlled trial of methotrexate in inflammatory hand OA demonstrated clinical benefit, suggesting a potential role for immunosuppression in a subset of patients with an inflammatory OA phenotype.
A new strategy to test investigational treatments for patients with OA is about to begin in patients who are at risk for accelerated development of OA following ACL reconstructive surgery.